Correlation Between Dynavax Technologies and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Eliem Therapeutics, you can compare the effects of market volatilities on Dynavax Technologies and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Eliem Therapeutics.
Diversification Opportunities for Dynavax Technologies and Eliem Therapeutics
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Dynavax and Eliem is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Eliem Therapeutics
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 4.83 times less return on investment than Eliem Therapeutics. But when comparing it to its historical volatility, Dynavax Technologies is 3.23 times less risky than Eliem Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 253.00 in Eliem Therapeutics on August 30, 2024 and sell it today you would earn a total of 51.00 from holding Eliem Therapeutics or generate 20.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Dynavax Technologies vs. Eliem Therapeutics
Performance |
| Timeline |
| Dynavax Technologies |
| Eliem Therapeutics |
Dynavax Technologies and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Eliem Therapeutics
The main advantage of trading using opposite Dynavax Technologies and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |